2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
134
Lung Neoplasms
50
Breast Neoplasms
24
Head and Neck Neoplasms
22
Adenocarcinoma of Lung
18
Brain Neoplasms
15
Neoplasms
14
Adenocarcinoma, Bronchiolo-Alveolar
11
Squamous Cell Carcinoma of Head and Neck
10
Glioblastoma
9
Esophageal Neoplasms
9
Colorectal Neoplasms
9
NSCLC
8
Rectal Neoplasms
7
Prostatic Neoplasms
7
Neoplasm Metastasis
7
Gliosarcoma
7
Colonic Neoplasms
7
Adenocarcinoma Of Esophagus
7
Ovarian Neoplasms
5
Esophageal Squamous Cell Carcinoma
5
Adenocarcinoma
5
Urinary Bladder Neoplasms
4
Central Nervous System Neoplasms
4
Carcinoma, Renal Cell
4
Carcinoma
4
Unspecified Adult Solid Tumor, Protocol Specific
3
Skin Neoplasms
3
Respiratory Tract Diseases
3
Kidney Neoplasms
3
Interventions
Gefitinib
1
Erlotinib Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Advanced Stage Non Small Cell Lung Cancer
×
Gefitinib
×
Clear all
NCT01955421
2015-07-03
NSCLC EGFR TKI
Sun Yat-sen University
Phase 2
Unknown
224 enrolled